Evidence map›Paper›PMID 29959437›Full record

Trial reportBone marrow transplantation2019

A prospective study of allogeneic transplantation from unrelated donors for chronic granulomatous disease with target busulfan-based reduced-intensity conditioning.

Tomoo Osumi, Daisuke Tomizawa, Toshinao Kawai, Mayumi Sako, Eisuke Inoue, Tetsuya Takimoto, Eiichiro Tamura, Toru Uchiyama, Ken-Ichi Imadome, Maki Taniguchi and 12 more

Abstract readClinical TrialLetterMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Tomoo OsumiChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Daisuke TomizawaChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.ORCID http://orcid.org/0000-0003-1520-7007
Toshinao KawaiDepartment of Immunology, National Center for Child Health and Development, Tokyo, Japan.
Mayumi SakoDepartment of Clinical Research Promotion, Division of Clinical Trials, Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan.
Eisuke InoueMedical Informatics, St. Marianna University School of Medicine, Kanagawa, Japan.
Tetsuya TakimotoDivision of Registration Management, National Center for Child Health and Development, Tokyo, Japan.
Eiichiro TamuraDepartment of Immunology, National Center for Child Health and Development, Tokyo, Japan.
Toru UchiyamaDepartment of Human Genetics, National Research Institute for Child Health and Development, Tokyo, Japan.
Ken-Ichi ImadomeDepartment of Advanced Medicine for Infections, National Center for Child Health and Development, Tokyo, Japan.
Maki TaniguchiChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Ryota ShiraiChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Masanori YoshidaChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Rie AndoChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Yusuke TsumuraChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Hiroshi FujiDepartment of Radiology, National Center for Child Health and Development, Tokyo, Japan.
Kana MatsumotoDepartment of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kyoto, Japan.
Yoko ShiodaChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Chikako KiyotaniChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Keita TerashimaChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Masafumi OnoderaDepartment of Immunology, National Center for Child Health and Development, Tokyo, Japan.
Kimikazu MatsumotoChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Motohiro KatoChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan. katom-tky@umin.ac.jp.ORCID http://orcid.org/0000-0001-5145-1774

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Granulomatous Disease, ChronicHematopoietic Stem Cell TransplantationTransplantation ConditioningUnrelated DonorsAdolescentAllograftsBusulfanChildChild, PreschoolHumansMaleProspective StudiesBusulfan

Identifiers

PMID29959437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.